Vir Biotechnology, Inc. Quarterly Return On Assets in % from Q2 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Vir Biotechnology, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2020 to Q3 2024.
  • Vir Biotechnology, Inc. Return On Assets for the quarter ending September 30, 2024 was -31 %, a 25.9% decline year-over-year.
  • Vir Biotechnology, Inc. annual Return On Assets for 2023 was -27.7 %, a 248% decline from 2022.
  • Vir Biotechnology, Inc. annual Return On Assets for 2022 was 18.8 %, a 52.5% decline from 2021.
  • Vir Biotechnology, Inc. annual Return On Assets for 2021 was 39.5 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -31 -6.38 -25.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -26 -15.9 -158% Apr 1, 2024 Jun 30, 2024
Q1 2024 -27 -21.6 -406% Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.7 -46.5 -248% Oct 1, 2023 Dec 31, 2023
Q3 2023 -24.6 -69.6 -155% Jul 1, 2023 Sep 30, 2023
Q2 2023 -10.1 -59.8 -120% Apr 1, 2023 Jun 30, 2023
Q1 2023 -5.33 -73.8 -108% Jan 1, 2023 Mar 31, 2023
Q4 2022 18.8 -20.7 -52.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 45 +54.5 Jul 1, 2022 Sep 30, 2022
Q2 2022 49.7 +79.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 68.4 +111 Jan 1, 2022 Mar 31, 2022
Q4 2021 39.5 +79.1 Oct 1, 2021 Dec 31, 2021
Q3 2021 -9.47 +30 +76% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.3 +13 +30.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.7 Oct 1, 2020 Dec 31, 2020
Q3 2020 -39.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 -42.3 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.